Health Trials

Symptomatic Genetic Dilated Cardiomyopathy (DCM)

1

Review clinical trials related to Symptomatic Genetic Dilated Cardiomyopathy (DCM). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

Danicamtiv is an investigational medication, which means it is still being studied and has not been approved. The purpose of this study is to learn how well danicamtiv works, how safe it is, how well people can take it when used in patients with genetic or familial dilated cardiomyopathy (DCM). There are currently no approved medicines made specifically to treat genetic or familial DCM.

Participants needed: 332
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Kardigan, Inc.Updated: Aug 18, 2026Locations: 78
Eligibility criteria

Completed 24 weeks of blinded study treatment (corresponding to the Week 26 Visi... [+2]

Acute coronary syndrome or hemodynamically significant epicardial coronary disea... [+4]

Read more